N Baiji Lists on Beijing Stock Exchange, Opens Up 347% on Debut
N Baiji (stock code 920201), a biomedical materials company, debuted on the Beijing Stock Exchange on September 24, 2026, opening at 75.00 yuan (up 347.23% from its 16.77 yuan IPO price). The stock closed at 72.35 yuan, a gain of 331.43%, with a turnover rate of 97.31%. The IPO was heavily oversubscribed, with an online allocation rate of just 0.01%.
IllustrationEditorial responsibility
- No named human review is recorded for this page.
- Reports are grouped by semantic similarity and deterministic rules. Language models may assist titles, summaries, translation and cross-source analysis; the page reads the event directly, while its address stays stable when the title changes.
- Summary covers the current reports
Cross-source coverage
Reporting timeline
Beijing Stock Exchange New Stock N Bairuiji Surges 388.13% at Morning Close on Debut
N Bairuiji (stock code 920201), a new stock on the Beijing Stock Exchange, surged 388.13% by the morning close on its first trading day, expanding from an opening gain of 347.23%. The stock saw a half-day trading volume of 5.7464 million shares, with a turnover of 482 million yuan and a turnover rate of 75.53%. According to Securities Times data, the company is primarily engaged in the research, development, production, and sales of biomedical materials. Its net profits for 2023, 2024, and 2025 were 50.0784 million yuan, 52.3116 million yuan, and 76.3401 million yuan, respectively. The company issued 8.2258 million shares at an issue price of 16.77 yuan, with a price-to-earnings ratio of 14.99 times. Strategic placement shares totaled 822,600 shares, accounting for 10% of the initial issuance. The online offering saw an effective subscription volume of 51,000,517,700 shares, with an effective subscription multiple of 6,888.94 times and 714,300 valid subscribers, resulting in an online allocation rate of 0.01%. The report notes this is news and not investment advice.
Read sourceN Baiji Surges Over 470% on Beijing Stock Exchange Debut, Hits 97 Yuan
On September 24, N Baiji (stock code 920201) surged on its debut on the Beijing Stock Exchange, opening sharply higher and rising over 478% to a high of 97 yuan per share. As of reporting, the stock had eased to 88.79 yuan, still up over 420%, giving it a market capitalization of 6.1 billion yuan with a turnover of 375 million yuan. N Baiji is a national-level specialized and new 'little giant' enterprise engaged in the R&D, production, and sales of biomedical materials, particularly for post-surgical tissue repair and anti-adhesion in gynecological procedures. The company reported revenues of 198 million yuan, 231 million yuan, and 284 million yuan for 2023, 2024, and 2025 respectively, with net profits of 50 million yuan, 52 million yuan, and 76 million yuan. It forecasts revenue of 230 million to 250 million yuan for the first nine months of 2026, representing year-on-year growth of 14.98% to 24.98%, and net profit of 60 million to 65 million yuan, up 5.29% to 15.03%.
Read sourceN Baorui Ji Debuts on Beijing Stock Exchange, Opens Up 347.23%
N Baorui Ji (stock code 920201) began trading on the Beijing Stock Exchange on September 24, 2026, with an opening price of 75.00 yuan, representing a surge of 347.23% above its initial public offering price of 16.77 yuan. The company specializes in the research, development, production, and sales of biomedical materials. Its listing application was accepted by the Beijing Stock Exchange on December 26, 2024, and the entire process from acceptance to listing took 637 days. According to data from Securities Times, the company issued 8.2258 million shares publicly, with a price-to-earnings ratio of 14.99 times. Strategic placement shares accounted for 10% of the initial offering. The online offering saw massive demand, with valid subscriptions totaling 51,000,517,700 shares, an oversubscription ratio of 6,888.94 times, and a final allotment ratio of just 0.01%. The company reported net profits of 50.0784 million yuan, 52.3116 million yuan, and 76.3401 million yuan for the years 2023, 2024, and 2025, respectively. The article also includes a table comparing recent Beijing Stock Exchange new listings by their first-day opening performance.
Read sourceShow 3 older updatesHide older updates
Beijing Stock Exchange Newcomer N Baijuij Surges 331.43% on Debut with 97.31% Turnover Rate
N Baijuij (stock code 920201), a new stock on the Beijing Stock Exchange (BSE), surged 331.43% on its first trading day, closing at 72.35 yuan per share. The stock opened even higher at a 347.23% gain before paring some gains. Trading volume reached 7.4042 million shares, with a turnover rate of 97.31% and total turnover of 609 million yuan. The company specializes in the R&D, production, and sale of biomedical materials. Its net profits for 2023, 2024, and 2025 were 50.0784 million yuan, 52.3116 million yuan, and 76.3401 million yuan, respectively. The IPO involved 8.2258 million shares at an issue price of 16.77 yuan, with a price-to-earnings ratio of 14.99 times. Strategic placement shares accounted for 10% of the offering. The online tranche saw massive demand, with 714,300 valid subscribers bidding for 51.0005177 billion shares, resulting in an oversubscription ratio of 6,888.94 times and a final allocation rate of just 0.01%. The article also provides a table showing recent BSE new stock first-day performances, highlighting significant volatility in the market.
Read sourceBeijing Stock Exchange Newcomer N Bairuiji Surges 388% in Morning Trading Debut
N Bairuiji (stock code 920201), a new stock on the Beijing Stock Exchange (BSE), made a strong debut on its first trading day. The stock opened with a gain of 347.23% and extended its rally to 388.13% by the morning close. During the half-day session, 5.7464 million shares were traded, generating a turnover of 482 million yuan, with a turnover rate of 75.53%. The company specializes in the research, development, production, and sale of biomedical materials. According to data from Securities Times, the company reported net profits of 50.0784 million yuan, 52.3116 million yuan, and 76.3401 million yuan for the years 2023, 2024, and 2025, respectively. The public offering consisted of 8.2258 million shares at an issue price of 16.77 yuan per share, with a price-to-earnings ratio of 14.99 times. Strategic placement shares accounted for 10% of the initial offering. The online offering saw an effective subscription volume of 51,000,517,700 shares, with an effective subscription multiple of 6,888.94 times and 714,300 valid subscribers, resulting in an online allocation rate of 0.01%. The article notes that this is a news report and does not constitute investment advice.
Read sourceN Baiji Lists on Beijing Stock Exchange, Opens Up 347% on Debut
N Baiji (stock code 920201) began trading on the Beijing Stock Exchange on September 24, 2026, with its opening price surging 347.23% to 75.00 yuan from its IPO price of 16.77 yuan. The company, which develops and sells biomedical materials, had its listing application accepted by the BSE on December 26, 2024, taking 637 days from acceptance to listing. The IPO consisted of 8.2258 million shares, with a price-to-earnings ratio of 14.99 times. The online offering saw massive demand, with an effective subscription of 51.0005 billion shares, a subscription ratio of 6,888.94 times, and a final allotment rate of just 0.01%. The company reported net profits of 50.0784 million yuan in 2023, 52.3116 million yuan in 2024, and 76.3401 million yuan in 2025. The article, sourced from Securities Times, also includes a table comparing the first-day opening performance of recent BSE-listed stocks, noting that N Baiji's 347% gain is significant but not the highest among recent listings.